Understanding Osteoporosis: Bone Loss, Density & Risk

Osteoporosis is a systemic skeletal disease characterized by low bone mass, microarchitectural deterioration, and increased fragility fracture risk.

Core Pathology

  • Loss of bone volume & density: Imbalance between osteoclast resorption and osteoblast formation.
  • Microarchitectural decay: Trabecular thinning, loss of connectivity; cortical porosity.

Diagnosis

  • DXA (T-score): ≤−2.5 at hip/spine = osteoporosis; −1.0 to −2.5 = osteopenia.
  • FRAX® tool: 10-year major osteoporotic/hip fracture probability.
  • Vertebral fracture assessment (VFA): Detects silent fractures.

Risk Factors

  • Age >65, female sex, menopause (estrogen loss), low BMI.
  • Glucocorticoids (>5 mg prednisone ≥3 mo), aromatase inhibitors, androgen deprivation.
  • Smoking, alcohol (>3 units/day), sedentary lifestyle.
  • Secondary causes: hyperparathyroidism, hyperthyroidism, celiac, RA, CKD.

Consequences

  • Hip, vertebral, wrist fractures → pain, disability, loss of independence, increased mortality (20–24% 1-year mortality post-hip fracture).

Prevention & Treatment

  • Calcium 1000–1200 mg/day (diet + supplement), Vitamin D 800–2000 IU/day.
  • Weight-bearing + resistance exercise.
  • Fall prevention (home safety, vision check, balance training).
  • Pharmacotherapy (bisphosphonates, denosumab, anabolics) per FRAX/guidelines.

Early detection and intervention prevent fractures and preserve quality of life.

Osteoporosis - Related Articles